Clinical significance of hepatic resection in hepatocellular carcinoma: Analysis by disease-free survival curves

Archives of Surgery

Volumn 135, Issue 12, 2000, Pages 1456-1459

  Sakon, Masato ^a   Umeshita, Koji ^a   Nagano, Hiroaki ^a   Eguchi, Hidetoshi ^a   Kishimoto, Shinichi ^a   Miyamoto, Atsushi ^a   Ohshima, Satoshi ^a   Dono, Keizo ^a   Nahamori, Shozo ^a   Gotoh, Mitsukazu ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 17544380855     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.135.12.1456     Document Type: Article

References (10)

1. Tsuda H, Oda T, Sakamoto M, Hirohashi S. Different pattern of chromosomal allele loss in multiple hepatocellular carcinoma as evidence of their multiclonal origin. Cancer Res. 1992;52:1504-1509.
2. Takenaka K, Adachi E, Nishizaki T, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology. 1993;19: 889-894.
3. Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinoma. Gastroenterology. 1989;96:527-529.
4. Hsu HC, Peng SY, Lai PL, et al. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinoma. Cancer. 1994;73:42-47.
5. Esumi M, Aritaka T, Arii M, et al. Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res. 1986;46:5767-5771.
6. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the P53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res. 1992;52:3674-3678.
7. Challen C, Lunec J, Warren W, Collier J, Bassendine MF. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology. 1992; 16:1362-1366.
8. Ikeda K, Saiton S, Arase Y, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis. Hepatology. 1993;18:47-53.
9. Oka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 1990;12:680-687.
10. Nishiguchi S, Kuroki T, Morimoto H, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346:1051-1055.